International Journal of Infectious Diseases (Jun 2022)

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection

  • Makoto Inada,
  • Masahiro Ishikane,
  • Mari Terada,
  • Akihiro Matsunaga,
  • Kenji Maeda,
  • Noriko Iwamoto,
  • Mugen Ujiie,
  • Satoshi Kutsuna,
  • Shinichiro Morioka,
  • Yukihito Ishizaka,
  • Hiroaki Mitsuya,
  • Norio Ohmagari

Journal volume & issue
Vol. 119
pp. 18 – 20

Abstract

Read online

We present a case of a 58-year-old Japanese man with a history of 2 previous COVID-19 infections, who received 2 doses of mRNA-1273 vaccine. We are not aware of any previous study regarding antibody tendency after 2 infections and 2 vaccinations. We evaluated his IgG titer of antispike protein and neutralizing activity from the first infection before and after 2 doses of vaccine. Both antispike IgG titer and neutralizing activity showed a tendency to decline almost 1 year after initial infection; they rapidly increased after the first vaccination, and they remained high after the second vaccination. Although this is a single case report, it seems to have generalizability because the findings are consistent with previous reports regarding single infections or 3 doses of vaccination. Our findings suggest that a single booster shot may provide sufficient protection and aid the understanding of immunologic responses of vaccination in patients with COVID-19 with history of re-infection.

Keywords